Karuna Therapeutics, Inc.

KRTX · NASDAQ
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Operating Activities
Net Income-$114-$119-$103-$98
Dep. & Amort.$0$0$0$0
Deferred Tax$113$0-$113$0
Stock-Based Comp.$23$18$18$16
Change in WC-$10$1$30-$12
Other Non-Cash-$123-$11$103-$7
Operating Cash Flow-$111-$110-$64-$101
Investing Activities
PP&E Inv.-$1-$1-$1-$1
Net Acquisitions-$1-$29$253$1
Inv. Purchases-$226-$368-$606-$321
Inv. Sales/Matur.$319$397$353$294
Other Inv. Act.$1$29-$253-$1
Investing Cash Flow$92$28-$254-$27
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$24$3$18$442
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$20$3$18$442
Financing Cash Flow$20$3$18$442
Forex Effect-$196$0$196$0
Net Chg. in Cash$1-$79-$299$314
Supplemental Information
Beg. Cash$185$264$563$249
End Cash$186$185$264$563
Free Cash Flow-$112-$111-$65-$101
Karuna Therapeutics, Inc. (KRTX) Financial Statements & Key Stats | AlphaPilot